Sensus Healthcare Stock (NASDAQ:SRTS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$7.15

52W Range

$1.91 - $7.18

50D Avg

$6.29

200D Avg

$5.24

Market Cap

$112.76M

Avg Vol (3M)

$130.08K

Beta

1.04

Div Yield

-

SRTS Company Profile


Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

35

IPO Date

Jul 26, 2016

Website

SRTS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Service$2.80M$3.17M$3.11M
Product$20.35M$1.01M$23.00K

Fiscal year ends in Dec 23 | Currency in USD

SRTS Financial Summary


Dec 23Dec 22Dec 21
Revenue$24.41M$44.53M$27.04M
Operating Income$-382.00K$14.83M$4.12M
Net Income$485.00K$24.24M$4.12M
EBITDA$30.00K$15.21M$4.12M
Basic EPS$0.03$1.47$0.25
Diluted EPS$0.03$1.46$0.25

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 11, 24 | 8:31 AM
Q1 24May 09, 24 | 12:00 AM
Q4 23Feb 08, 24 | 9:59 PM

Peer Comparison


TickerCompany
TBIOTelesis Bio, Inc.
AIMDAinos, Inc.
RCELAVITA Medical, Inc.
INVOINVO Bioscience, Inc.
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
LNSRLENSAR, Inc.
SSKNSTRATA Skin Sciences, Inc.
LUNGPulmonx Corporation
NVNOenVVeno Medical Corporation
CLPTClearPoint Neuro, Inc.
IRIXIRIDEX Corporation
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
KIDSOrthoPediatrics Corp.
AZYOElutia Inc.
AXGNAxoGen, Inc.
CVRXCVRx, Inc.
LUCDLucid Diagnostics Inc.
RXSTRxSight, Inc.